The 2.5 mg dose is better called the low-dose starter, because it is the labeled start and now has short direct non-diabetic data behind it. Microdosing has been used for tolerability testing, metabolic-marker support, step-down protocols, and maintenance, not for proven long-term obesity outcomes
NNMT has been explored as a target in obesity, insulin resistance, and age-related metabolic decline, supporting the rationale for translational research into body composition and performance contexts (Kannt & Pfenninger, Frontiers in Physiology )
Post-Surgery Patients : People who have undergone intestinal surgery, including weight loss surgery (like gastric bypass), may have reduced capacity to absorb B12
Hirayama, K., Endo, K., Kawamura, S
Tirzepatide side effects Tirzepatide side effects follow a similar gastrointestinal pattern but with some notable differences
This breadth of application speaks to the fundamental nature of the healing processes that BPC-157 supports